Feasibility and Therapeutic Potential of 177Lu–Fibroblast Activation Protein Inhibitor–46 for Patients With Relapsed or Refractory Cancers
2019 ◽
Vol 60
(12)
◽
pp. 1743-1749
◽
2011 ◽
Vol 11
(12)
◽
pp. 1447-1463
◽
Keyword(s):